Single vs. combination immunotherapeutic strategies for glioma

Por Chandran, Mayuri, Candolfi, Marianela, Shah, Diana, Mineharu, Yohei, Yadav, Vivek, Koschmann, Carl, Asad, Antonela S., Lowenstein, Pedro R., Castro, Maria G.
Publicado no Expert Opin Biol Ther (2017)

IMMU-26. TLR7 ACTIVATION IS ESSENTIAL FOR NK CELLS TO ELIMINATE GLIOMA TUMORS

Por Shah, Diana, Kadiyala, Padma, Kamran, Neha, Baker, Gregory J, Doherty, Robert, Zamler, Dan, Nuñez, Gabriel, Castro, Maria G, Lowenstein, Pedro R
Publicado no Neuro Oncol (2017)

Current state and future prospects of immunotherapy for glioma

Por Kamran, Neha, Alghamri, Mahmoud S, Nunez, Felipe J, Shah, Diana, Asad, Antonela S, Candolfi, Marianela, Altshuler, David, Lowenstein, Pedro R, Castro, Maria G
Publicado no Immunotherapy (2018)

Immunosuppressive Myeloid Cells’ Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy

Por Kamran, Neha, Kadiyala, Padma, Saxena, Meghna, Candolfi, Marianela, Li, Youping, Moreno-Ayala, Mariela A., Raja, Nicholas, Shah, Diana, Lowenstein, Pedro R., Castro, Maria G.
Publicado no Mol Ther (2017)